Insider sale
DYNE THERAPEUTICS, INC.
$35.30M
1.36M shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 1.36M shares of DYNE THERAPEUTICS, INC. valued at approximately $35.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001628280-26-057190
10% Owner
Since Sep 2020
1.36M
Shares to sell
$35.30M
Approx. market value
1.36M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
1.36MTotal acquired1.36M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 1.36M | — |
| Total | 1.36M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
1.36M
Market value
$35.30M
8/14/2026
Total
Units
1.36M
Value
$35.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2026 | 1.36M | $35.30M | Nasdaq | Planned |
| Total | 1.36M | $35.30M | ||